Anthea Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANTHEA PHARMA
ANTHEA PHARMA has eight approved drugs.
Summary for Anthea Pharma
| US Patents: | 0 |
| Tradenames: | 8 |
| Ingredients: | 8 |
| NDAs: | 8 |
Drugs and US Patents for Anthea Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anthea Pharma | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 219883-004 | Oct 8, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Anthea Pharma | PROPOFOL | propofol | INJECTABLE;INJECTION | 220857-001 | Jul 14, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Anthea Pharma | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 219883-003 | Mar 21, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
